Related Experiment Video
Updated: Jun 22, 2026

Methods for the Modulation and Analysis of NF-κB-dependent Adult Neurogenesis
Published on: February 13, 2014
Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation
Daniela Marasco1, Romania Stilo, Annamaria Sandomenico
1Istituto di Biostrutture e Bioimmagini (IBB), CNR, 80134, Napoli, Italy.
Abstract:
The molecular complex containing BCL10 and CARMA [CARD (caspase recruitment domain)-containing MAGUK (membrane-associated guanylate kinase)] proteins has recently been identified as a key component in the signal transduction pathways that regulate activation of the transcription factor NF-kappaB (nuclear factor kappaB) in lymphoid and non-lymphoid cells. Assembly of complexes containing BCL10 and CARMA proteins relies on homophilic interactions established between the CARDs of these proteins. In order to identify BCL10-inhibitory peptides, we have established a method of assaying peptides derived from the CARD of BCL10 in binding competition assays of CARD-CARD self-association. By this procedure, a short peptide corresponding to amino acid residues 91-98 of BCL10 has been selected as an effective inhibitor of protein self-association. When tested in cell assays for its capacity to block NF-kappaB activation, this peptide represses activation of NF-kappaB mediated by BCL10, CARMA3 and PMA/ionomycin stimulation. Collectively, these results indicate that residues 91-98 of BCL10 are involved in BCL10 self-association and also participate in the interaction with external partners. We also show that blocking of the CARD of BCL10 may potentially be used for the treatment of pathological conditions associated with inappropriate NF-kappaB activation.
Insights
Researchers identified a BCL10 peptide (residues 91-98) that inhibits self-association and blocks NF-kappaB activation. This finding offers potential therapeutic strategies for diseases linked to aberrant NF-kappaB signaling.
Area of Science:
- Molecular biology
- Cell signaling
- Immunology
Background:
- The BCL10-CARMA protein complex is crucial for NF-kappaB transcription factor activation.
- Complex assembly involves homophilic interactions between CARD domains of BCL10 and CARMA proteins.
Purpose of the Study:
- To identify BCL10-inhibitory peptides.
- To investigate the role of BCL10 self-association in NF-kappaB signaling.
Main Methods:
- Developed an assay for BCL10 CARD peptides in CARD-CARD self-association binding competition.
- Screened BCL10-derived peptides to identify inhibitors of protein self-association.
- Tested the inhibitory peptide in cell assays for NF-kappaB activation.
Main Results:
- A peptide (residues 91-98) effectively inhibited BCL10 self-association.
- This peptide repressed NF-kappaB activation mediated by BCL10, CARMA3, and PMA/ionomycin.
- Residues 91-98 of BCL10 are involved in self-association and interactions with other partners.
Conclusions:
- The BCL10 CARD peptide (91-98) is a potent inhibitor of BCL10 self-association.
- Blocking BCL10 CARD interactions may offer a therapeutic approach for conditions with inappropriate NF-kappaB activation.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway
Canonical Wnt Signaling Pathway

